Venture Capital Investors

TVM Capital

VC investing group TVM Capital provides capital to promising tech companies.

Venture Investor Overview

Venture Investor
TVM Capital
Status
Active
Investor Type
Venture Capital
Activity Level
73 transactions
Funds Raised
At least $801.6 million
Industry Focus
Healthcare IT
Healthcare Services
Life Sciences
Medical Devices & Instruments

Contact Information

Contact
Helmut Schuehsler
Title
Chief Executive Officer
Mailing Address
Ottostraße 4
Munich, 80333
Germany
Phone
+49 (89) 998 992-0
Website
www.tvm-capital.com
Email Address
[email protected]

Background Information

Overview
TVM Capital, founded in 1983, is one of the first venture capital funds formed in Germany and a leader in transatlantic operations. For many years, TVM Capital has focused on information & communications technology and life sciences, high growth sectors where innovation, effective management and sound financial backing have enormous impact on company growth.
Profile
TVM Capital LinkedIn Company Profile
Social Media
TVM Capital Company Twitter Account
Company News
TVM Capital News
Facebook
TVM Capital on Facebook
YouTube
TVM Capital on YouTube
Last Transaction
4/22/2024

Transaction History

Our records indicate that TVM Capital invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Smart Reporting
4/22/2024
$24,600,000
Vektor Medical
2/5/2024
$16,000,000
Myosotis
1/31/2024
$8,590,000
DEBx Medical
5/22/2023
$10,742,000
AMILI
6/15/2022
$10,500,000
Access Vascular
3/4/2021
$20,000,000
Emovi
3/6/2019
$11,219,853
Rapid Micro Biosystems
5/3/2018
$60,000,000
AurKa Pharma
9/19/2016
Unknown
Acer Therapeutics
5/11/2016
$8,150,000
Esperas Pharma
4/15/2015
Unknown
CoLucid Pharmaceuticals
1/13/2015
$37,100,000
FAAH Pharma
8/13/2014
Unknown
Proteon Therapeutics
5/16/2014
$45,000,000
Rapid Micro Biosystems
4/16/2014
$6,001,413
Rapid Micro Biosystems
6/26/2013
$32,600,000
Kaneq Bioscience
1/23/2013
Unknown
Argos Therapeutics
9/30/2012
$14,378,100
Argos Therapeutics
4/24/2012
$25,000,000
bluebird bio
4/20/2011
$30,000,000
Anchor Therapeutics
8/20/2010
$10,000,000
Precision Therapeutics
6/11/2010
$35,000,000
bluebird bio
3/12/2010
$35,000,000
Ubidyne
8/20/2009
$14,400,000
Rapid Micro Biosystems
7/8/2009
$18,600,000
Anchor Therapeutics
6/30/2009
$10,000,000
Proteon Therapeutics
3/5/2009
$38,000,000
Anchor Therapeutics
12/31/2008
$9,999,900
SelectX Pharmaceuticals
12/31/2008
$21,500,000
ExtendMedia
12/1/2008
$10,000,000
Argos Therapeutics
11/24/2008
$35,200,000
Calabrio
9/30/2008
$500,000
Enigma Semiconductor
9/30/2008
$9,354,000
BitWave
8/19/2008
$10,000,000
CoreOptics
5/14/2008
$25,000,000
Ubidyne
5/14/2008
$34,000,000
Concert Pharmaceuticals
4/30/2008
$37,000,000
EUSA Pharma
3/11/2008
$50,000,000
Transave
12/31/2007
$15,500,000
Enigma Semiconductor
11/27/2007
$5,600,000
Anchor Therapeutics
11/2/2007
$8,000,000
Streaming 21
9/30/2007
$2,000,000
bluebird bio
6/30/2007
$5,429,900
Arteris
6/20/2007
$8,100,000
Proteon Therapeutics
4/6/2007
$12,000,000
ExtendMedia
4/5/2007
$12,000,000
Streaming 21
3/31/2007
$1,000,000
Impress Software
12/31/2006
$4,000,000
Concert Pharmaceuticals
11/30/2006
$48,500,000
Cerenis Therapeutics
11/13/2006
$53,500,000
RenaMed Biologics
9/7/2006
$40,000,000
Magen BioSciences
8/28/2006
$15,400,000
Concert Pharmaceuticals
7/17/2006
$10,000,000
VPIsystems
6/30/2006
$700,000
bluebird bio
6/30/2006
$8,592,000
Clearsight Systems
6/30/2006
$5,550,000
Magen BioSciences
3/31/2006
$1,840,000
Transave
3/31/2006
$17,824,000
VPIsystems
3/31/2006
$2,315,000
Amnis
3/31/2006
$8,250,000
BitWave
3/31/2006
$4,789,000
Proteon Therapeutics
3/30/2006
$19,000,000
BioXell SpA
3/15/2006
$13,475,200
Precision Therapeutics
2/21/2006
$20,000,000
Impress Software
9/12/2005
$10,000,000
BitWave
6/30/2005
$6,000,000
Enigma Semiconductor
6/30/2005
$4,500,100
Clearsight Systems
6/30/2005
$1,000,000
Sirtris Pharmaceuticals
3/31/2005
$27,000,000
Aventeon
3/31/2005
$5,000,100
Impress Software
11/15/2004
$8,000,000
bluebird bio
10/6/2004
$12,000,000
ClearCube Technology
1/7/2003
$20,000,000

 

Investor Contacts

Title
Name
Email & Social
Partner
Hoda Abou-Jamra
  Hoda Abou-Jamra LinkedIn Profile  Hoda Abou-Jamra Twitter Account  Hoda Abou-Jamra News  Hoda Abou-Jamra on Facebook
Managing Partner
Hubert Birner
  Hubert Birner LinkedIn Profile  Hubert Birner Twitter Account  Hubert Birner News  Hubert Birner on Facebook
Managing Partner
Luc Marengere
  Luc Marengere LinkedIn Profile  Luc Marengere Twitter Account  Luc Marengere News  Luc Marengere on Facebook
Chief Executive Officer
Helmut Schühsler
  Helmut Schühsler LinkedIn Profile  Helmut Schühsler Twitter Account  Helmut Schühsler News  Helmut Schühsler on Facebook

 

Funds

Our database includes the following fund closing(s) for TVM Capital. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
TVM Life Science Ventures VII
10/6/2014
$201,600,000
TVM Life Science Ventures VI
6/30/2005
$298,900,000
TVM V Life Science Ventures
6/30/2001
$301,100,000

 

Portfolio Companies

TVM Capital has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Access Vascular
Acer Therapeutics
AMILI
Amnis
Anchor Therapeutics
Argos Therapeutics
Arteris
AurKa Pharma
Aventeon
BioXell SpA
BitWave
bluebird bio
Calabrio
Cerenis Therapeutics
ClearCube Technology
Clearsight Systems
CoLucid Pharmaceuticals
Concert Pharmaceuticals
CoreOptics
DEBx Medical
Emovi
Enigma Semiconductor
Esperas Pharma
EUSA Pharma
ExtendMedia
FAAH Pharma
Impress Software
Kaneq Bioscience
Magen BioSciences
Myosotis
Precision Therapeutics
Proteon Therapeutics
Rapid Micro Biosystems
RenaMed Biologics
SelectX Pharmaceuticals
Sirtris Pharmaceuticals
Smart Reporting
Streaming 21
Transave
Ubidyne
Vektor Medical
VPIsystems

 

 

 

 

Browse more venture capital investors:

TVC Capital | TVP

 

Share this article

 

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a market leader in private equity transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.